mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.2 |
6e-05 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-05 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.2 |
8e-05 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.18 |
0.0002 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0005 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.0006 |